Latest Safety News

Actinogen Medical’s pivotal XanaMIA trial for Alzheimer’s disease has received a green light from its independent Data Monitoring Committee to continue, reinforcing confidence in the drug’s safety and efficacy profile.

Kaiser Reef Limited reported a robust December quarter with nearly 7,000 ounces of gold produced at Henty, a 29% increase in gold reserves, and a strengthened cash position of A$43.1 million.

Tolu Minerals Limited reports steady progress at its Tolukuma Gold Mine, advancing a major mine expansion project targeting 500 tonnes per day production by the first quarter of 2027. Key infrastructure developments, drilling expansion, and processing plant refurbishments underpin the company’s growth strategy.

Kingsgate Consolidated has delivered a stellar December quarter, boosting cash reserves by 56% and maintaining robust production guidance for FY26 amid favourable gold and silver prices.

Peninsula Energy reports strong progress at its Lance Uranium Project in Wyoming, with key production milestones reached and the company on track to meet 2026 uranium output targets amid a buoyant market.

OncoSil Medical has reported a record quarter for dose sales alongside key European market entries and a successful manufacturing milestone, signalling growing momentum for its pancreatic cancer treatment.

Terragen Holdings reports a strong quarter with an 87% increase in sales of its ruminant probiotic and advances key livestock and crop trials, positioning itself for expanded market access.

TerraCom Limited reported a stable operational quarter despite logistical challenges impacting coal shipments and cash flow, while successfully raising A$60 million to bolster liquidity. The Blair Athol mine life was extended to 2033, underpinning the company’s long-term outlook.

Livium Ltd has solidified its position in the clean energy recycling sector with new contracts, a key patent, and a $4.5 million capital raise, setting the stage for accelerated growth in lithium-ion battery and rare earth element recycling.

Noxopharm has successfully completed dosing in its HERACLES clinical trial for SOF-SKN™, demonstrating strong safety and tolerability. The company also secured a new overseas partnership and its first US patent for the Sofra platform.

Beetaloo Energy has secured key regulatory approvals and approved the Final Investment Decision for its Carpentaria Pilot Project, setting the stage for first gas sales from EP187 in late 2026.

Entropy Neurodynamics has successfully enrolled and dosed the first patient in its pioneering clinical trial of TRP-8803, an intravenous psilocin formulation targeting Binge Eating Disorder, while securing $6.1 million in new funding to accelerate development.